Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis

Stein Gold L, et al. Br J Dermatol. 2026;195(4):600.


Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials

DOWNLOAD PUBLICATION